Elite Pharmaceuticals Inc (ELTP)

[jour_trader]

What a surprise! Welcome back. Does this mean we’ll see Langston back as well?

Nice to see price climb today, but bid support on L2 is pretty thin to be back where we were yesterday.

Whether you look at revenue or potential near-term EBITDA multiples, Elite has a long way to go to fare well in an acquisition for shareholders. I think it will still be several years before anything like that takes place. We don’t have much insight to look at what 2021 revenues and beyond look like as well as the pipeline and ability to develop to the finish line.

Nasrat’s ownership could be sold outside an acquisition as we sometimes see significant owners cashing out in their company to a larger investor. I think about half of M&A life science acquisitions include a mgmt carveout to ensure management gets a sweet deal as well due for warrants/options and breathing. Something I have no doubt Nasrat will be sure to include.